AtriCure, Inc.

ATRCNASDAQHealthcare● Active

$26.92

$-0.19(-0.68%)

Market Cap$1.4B

P/E Ratio—

52W High$43.18

52W Low$25.36

Avg Volume749K

Open$27.18

Beta1.26

Free Cash Flow Financials Revenue

AtriCure, Inc. (ATRC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ATRC · free cash flow · updated Jun 9, 2026

Core FCF metrics

ATRC · FCF · TTM · margin & CAGR

Free cash flow was $48.3M for FY2025 (fiscal year ending 2025-12-31), up 529.0% year-over-year The FCF margin was 9.0%.

FY2025 Free Cash Flow$48.3M▲ +529.0% YoY

Trailing 12M (TTM)$53.6Mtrailing 4 quarters sum

FCF Margin9.0%$48.3M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ATRC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$57.3M(9M)$48.3M▲ +529.0%9.0%

FY2024$12.2M(23M)−$11.3M▲ +70.0%-2.4%

FY2023$4.5M(42M)−$37.5M▲ +3.9%-9.4%

FY2022−$22.1M(17M)−$39.0M▼ 65.8%-11.8%

FY2021−$13.8M(10M)−$23.5M▲ +6.3%-8.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ATRC · P/FCF · FCF yield · FCF per share

AtriCure, Inc. (ATRC) trades at a FCF yield of 3.94% and a price-to-free-cash-flow ratio of 24.0x. FCF per share stands at $1.12, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

3.94%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.12

TTM FCF ÷ Shares Outstanding

Price / FCF

x24.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x24.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

ATRC · cash flow statement · operating / investing / financing

For FY2025, AtriCure, Inc. generated $57.3M in operating cash flow and spent 9M in capital expenditures, yielding $48.3M in free cash flow.

Operating Activities

+$57.3M

Cash from core business operations

2025-12-31

Investing Activities

−$14.6M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$1.2M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($57.3M) − |CapEx| (9M) = FCF ($48.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ATRC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

AtriCure, Inc.YOU

ATRC

$48.3M+529.0%9.0%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

AtriCure, Inc. (ATRC) reported free cash flow of $48.3M for FY2025 (fiscal year ending 2025-12-31), up 529.0% year-over-year. The FCF margin was 9.0%.

Based on available data, AtriCure, Inc. has maintained positive free cash flow for at least 1 fiscal year(s). FCF peaked at $48.3M in FY2025.

AtriCure, Inc.'s FCF yield is 3.94% and price-to-FCF ratio is 24.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ATRC free cash flow · 8 questions

AtriCure, Inc. free cash flow was $48.3M for FY2025, up 529.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $53.6M.

ATRC free cash flowATRC FCFATRC FCF 2025ATRC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · AtriCure, Inc. · AtriCure, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026